Add Yahoo as a preferred source to see more of our stories on Google. Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access ...
Lilly says most Medicare plans will honor the $50 cap, but some basic Part D plans may require higher out-of-pocket costs.
Eli Lilly (LLY) has said that monthly out-of-pocket costs for some Medicare enrollees taking its weight loss and obesity drugs could exceed the $50 cap under a new government-backed payment model. The ...
Hosted on MSN
Medicare to Cover Obesity Drugs Under Trump Deal for as Little as $50. What You Need to Know
The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact Medicare beneficiaries and others in the coming months. The agreement cuts ...
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.The drugs are ...
The MarketWatch News Department was not involved in the creation of this content. Centennial, Colorado--(Newsfile Corp. - December 24, 2025) - The Obesity Medicine Association (OMA) released its ...
or on the link below. This OMA Position Statement is intended to provide a preliminary overview of emerging policies regarding Medicare and Medicaid coverage of obesity medications, as well as ...
Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results